V

VB Spine

Develops spine medical technologies and tools

Senior Manager, Product Management - Advanced Visualization Portfolio

Full-TimeUpdated on 10/21/2026
$160k - $180k/yr+ Bonuses + Incentives + 401(k) Match
Expert
Bachelor's, MBA
Leesburg, VA, USA
In Person
ProductProduct Management

About the job

Requirements
  • A bachelor's degree is required.
  • At least 10 years of professional experience is required.
  • At least 7 years of experience in medical devices, marketing, or sales is required.
  • Strong strategic thinking, analytical, and problem-solving skills are required.
  • Excellent communication, presentation, and interpersonal abilities are required.
  • The ability to manage multiple priorities and influence without direct authority is required.
  • The ability to navigate complex organizational structures and drive alignment is required.
  • Proficiency in Microsoft Office, including Excel, Word, and PowerPoint, is required.
Responsibilities
  • Lead full product lifecycle management, including launch planning, commercialization, multi-generational roadmapping, and end-of-life strategy.
  • Define portfolio strategy, including positioning, pricing, market access, procedure development, and go-to-market execution.
  • Partner with R&D, Clinical, and Regulatory teams to align new product development with customer needs and brand strategy.
  • Establish and oversee clinical evidence generation and claims strategy to support product adoption and reimbursement.
  • Develop and execute long-range strategic plans and annual marketing plans aligned with business objectives and growth targets.
  • Partner in integrated business planning to align commercial expectations with operational capabilities.
  • Establish pricing strategy, including contract pricing, to optimize revenue, margin, and competitive positioning.
  • Advise on commercial models, channel strategy, and sales enablement to support business growth.
  • Manage marketing budgets and contribute to P&L performance through disciplined investment decisions.
  • Translate commercial strategy into accurate demand forecasts using market trends, sales inputs, inventory data, and product lifecycle insights.
  • Collaborate with Supply Chain and Operations to ensure alignment on capacity, supply continuity, and inventory targets.
  • Identify and mitigate risks related to supply disruption, excess inventory, and product obsolescence.
  • Lead lifecycle transition planning to minimize inventory exposure and optimize product transitions.
  • Lead market research and competitive analysis to identify growth opportunities and emerging trends.
  • Build and maintain relationships with key opinion leaders, translating insights into actionable strategy.
  • Conduct financial and operational analyses to inform business decisions and portfolio performance.
  • Establish KPIs and evaluate performance through post-launch and ongoing portfolio reviews.
  • Provide clear strategic direction and technical expertise to the sales organization.
  • Develop and deliver training and education programs for internal teams, customers, and key opinion leaders.
  • Lead marketing communications strategy to maximize reach, engagement, and adoption.
  • Evaluate and refine commercial programs to improve effectiveness and impact.
  • Lead, coach, and develop a high-performing product management team.
  • Build strong cross-functional relationships and alignment across the organization.
  • Make high-impact decisions that influence business performance and long-term growth.
  • Drive process improvements and remove obstacles to enable team success.
Desired Qualifications
  • An MBA is preferred.
  • Capital equipment experience is preferred.

About the company

V

VB Spine

View
Website

VB Spine is a spine-focused medical technology company that develops and distributes tools and resources for healthcare professionals to improve spine health and patient outcomes. Its products and collaborations include access to technologies like Mako Spine and Copilot through a strategic partnership with Stryker, enabling advanced planning, precision, and guidance in spine procedures. The company differentiates itself by being the largest privately held spine-focused business and a family-owned firm within the musculoskeletal space, emphasizing people, partnerships, and operational execution. Its goal is to advance spine care by expanding access to high-quality technologies and partnering with healthcare providers and other industry leaders to drive better clinical results.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Leesburg, Virginia

Founded

2025

Get referred to VB Spine

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 France distribution center cuts European delivery times and improves surgeon responsiveness.
  • May 2026 First Citizens financing lowers hospital purchase friction for VB Spine Solutions.
  • February 2026 Vulcan limited release and October 2026 SRS visibility can accelerate adoption.

What critics are saying

  • Augmedics integration and Vulcan launch demand flawless execution across regulatory and commercial teams.
  • Stryker, Globus, and Medtronic can outspend VB Spine on evidence and hospital contracting.
  • If ScolimiR-3D stalls clinically, VB Spine loses a core differentiation story entirely.

What makes VB Spine unique

  • VB Spine pairs implants, navigation, diagnostics, and financing under one platform.
  • The Viscogliosi brothers control execution, partnerships, and capital without public-market pressure.
  • ScolimiR-3D adds predictive scoliosis risk testing, a rarer layer than standard hardware.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Hybrid Work Options
  • Professional Development Budget
  • Training Programs

Company News

InfoMed News
Sep 29th, 2026
VB Spine announces FDA Breakthrough Device Designation for new blood test designed to identify patients at risk for scoliosis progression.

VB Spine announces FDA Breakthrough Device Designation for new blood test designed to identify patients at risk for scoliosis progression. colimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic scoliosis based on progression risk VB Spine LLC ("VB Spine"), the largest privately-held spine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D, an in vitro diagnostic blood test designed to assess the risk of disease progression in patients diagnosed with adolescent idiopathic scoliosis (AIS). The designation is the first granted to a predictive diagnostic scoliosis risk assessment test. ScolimiR-3D uses a standard blood draw to measure six circulating microRNAs associated with AIS progression and classify a patient's risk of developing a severe spinal curve. Dr. Alain Moreau and colleagues at the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, part of the Centre de recherche Azrieli du CHU Sainte-Justine and Université de Montréal, developed the underlying science, which was published in Scientific Reports.[1] In that study of 116 AIS patients, the six-microRNA panel that forms the basis of ScolimiR-3D predicted the risk of developing severe scoliosis with 100% sensitivity and 100% specificity in the study's validation testing. "For decades, physicians have had limited tools to determine which patients with adolescent idiopathic scoliosis are most likely to experience disease progression," said Dr. Moreau. "The challenge in scoliosis is not simply detecting the curve - it is knowing where that curve is going. ScolimiR-3D was developed to bring that predictive dimension into clinical care: using a simple blood test to identify progression risk earlier, when there is still an opportunity to personalize treatment and potentially change a patient's trajectory." The role of VB Spine in advancing scoliosis treatments. Scoliosis management today is largely reactive, with treatment decisions typically made only after curvature has progressed. ScolimiR-3D gives physicians the opportunity to structure conservative treatments, such as bracing, to align with the patient's risk assessment. It also serves as an additional resource for counseling families across the continuum of care, from diagnosis through treatment planning, by providing a predictive risk assessment that goes beyond the traditional "wait and see" approach. "Receiving FDA Breakthrough Device Designation is a significant milestone for this technology and for the future of scoliosis care," said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers and fellow co-CEOs Anthony and John Viscogliosi. "ScolimiR-3D will provide physicians with insights that support earlier, more informed decision-making. We're proud to work alongside Dr. Moreau and his team to advance this work." The Breakthrough Devices Program is intended to provide patients and health care providers with timely access to more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. VB Spine's collaboration with Dr. Moreau has also been recognized through a nomination for the Scoliosis Research Society's Hibbs Award. Additional research supporting the technology is expected to be presented at the Scoliosis Research Society (SRS) 2026 Annual Meeting, October 6-10 in Sydney, Australia.

Associated Press
Jul 9th, 2026
VB Spine launches European distribution centre in France to cut delivery times

VB Spine, a global family-owned spine company, has begun shipping orders from its European distribution centre in Cestas, France. The facility, which started accepting orders on 1 June 2026, serves as the primary distribution hub for VB Spine products across Europe. The centre is located within VB Spine's Cestas campus, which the company acquired in January 2026. The site integrates manufacturing, distribution, human resources, marketing and surgeon support services. Co-CEO John Viscogliosi said the centre reduces fulfilment and response times for European customers. The company is also developing regional distribution centres in Canada, Germany, Great Britain, Italy, Japan, Poland and Spain. VB Spine describes itself as the largest privately held spine company globally.

MobiHealthNews
Jul 7th, 2026
Philips releases AI-powered toothbrush and more digital health news.

Philips releases AI-powered toothbrush and more digital health news. VB Spine signs an agreement to acquire Augmedics' CT-to-fluoroscopy technology, and Oova integrates with Oura to allow women to track hormonal data. Royal Philips has announced the release of the Sonicare DiamondClean 9900 Prestige, an on-device, AI-powered toothbrush with a spatially aware guidance system. The toothbrush's real-time light ring guidance system displays how well users are brushing, including coverage, pressure or scrubbing. Philips' toothbrush has eight modes with three intensities and includes a 12-segment "Mouth Map" on the toothbrush's display to show spots a user has missed while brushing. "With our Next-Generation DiamondClean 9900 Prestige, we fundamentally reimagined the brushing experience by combining advanced sensing, real-time guidance and AI-powered personalization directly within the toothbrush itself," Francesco Grillo, Philips global business unit leader in oral healthcare, said in a statement. VB Spine, a company that develops spine tools for surgical teams, entered into a definitive agreement to acquire the exclusive rights to augmented reality surgical navigation platform Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology. FDA 510(k)-cleared CT-Fluoro allows surgeons to perform image-guided surgery from a preoperative CT scan as well as from fluoroscopic images obtained with a standard 2D C-arm, meaning surgeons may not need to pause a procedure to acquire a new 3D scan while the patient is on the operating table. VB Spine previously acquired the Augmedics xvision Spine System platform in April, adding augmented-reality surgical navigation tools to its portfolio. "At VB Spine, our goal is to remove barriers that prevent surgeons from accessing technologies that improve procedural efficiency and patient care," Marc Viscogliosi, co-CEO of VB Spine, said in a statement. "The addition of CT-Fluoro technology for spine applications will be an important step forward for the xvision platform because it provides surgeons with greater flexibility in how they utilize navigation." Longitudinal hormone intelligence company Oova has announced a new integration with Oura to sync Oura Ring data on sleep, recovery, mood and energy with Oova's offerings around symptoms and hormones to examine shifts in biological patterns. Oova offers clinical-grade hormone monitoring kits that provide levels of LH, estrogen and progesterone as well as an AI-enabled app with tools to help navigate perimenopause, manage fertility treatment and understand cycle patterns. The integration is available to Oova users with an active Oura membership. "Wearables have become remarkably good at telling women what happened," Dr. Amy Divaraniya, Founder and CEO of Oova, said in a statement. "But most women are still left wondering why. By bringing hormone data, symptom tracking, and wearable insights together, we're helping women understand the biological patterns behind how they feel."

First Citizens
May 12th, 2026
First Citizens Bank Launches New Equipment Financing Solution For VB Spine Solutions

First Citizens Bank launches new Equipment Financing solution for VB Spine Solutions. Raleigh, NC - May 12, 2026 - First Citizens Bank's Healthcare Equipment Finance group today announced a new private label financing solution with VB Spine to provide hospitals, ambulatory surgical centers and other healthcare providers with lending and leasing solutions for VB Spine Solutions, a unique program that helps hospitals bring critical spine technology online faster, with structures built around patient need. Headquartered in Leesburg, Virginia, VB Spine provides solutions designed to improve access to modern spine care across various treatment settings. The company's latest program, VB Spine Solutions, works with hospitals to simplify how capital equipment is placed, so surgeons and care teams can focus on better patient outcomes. "With their expertise in healthcare financing and understanding of the growing spine market, we knew that First Citizens was the right partner for VB Spine Solutions," said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers and fellow co-CEOs Anthony and John Viscogliosi. "This relationship combines VB Spine's technology and clinical focus with the scale and reliability of a leading financial institution, creating a path for surgeons to get the tools they need to better serve the patient." "We are thrilled to work with VB Spine and provide a specialized financing solution that will increase access to its innovative spine care program," said Todd Beaver, who leads the Healthcare Equipment Finance group at First Citizens Bank. "We look forward to continuing to support VB Spine and its mission to deliver improved patient outcomes with specialized spine surgery solutions." First Citizens Healthcare Equipment Finance group provides an array of lending and leasing solutions to equipment manufacturers and vendors who support hospitals, healthcare systems and ambulatory surgical centers nationwide. Learn more here: Business Equipment Financing & Loans | First Citizens Bank About First Citizens Bank First Citizens Bank helps personal, business, commercial and wealth clients build financial strength that lasts. Headquartered in Raleigh, N.C., First Citizens has built a unique legacy of strength, stability and long-term thinking that has spanned generations. First Citizens offers an array of general banking services including a network of branches and offices nationwide; commercial banking expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation banking serving businesses at every stage; and a nationwide direct bank. Parent company First Citizens BancShares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $230 billion in assets and a member of the Fortune 500(TM). Discover more at firstcitizens.com.

Business Wire
Apr 30th, 2026
VB Spine launches hospital partnership programme to speed up spine technology access

VB Spine has launched VB Spine Solutions, a programme designed to help US hospitals acquire spine technology more quickly by removing traditional capital barriers. The initiative provides access to capital equipment owned by VB Spine and other manufacturers through flexible partnership structures. The programme aims to streamline equipment placement so surgeons can focus on patient outcomes rather than procurement processes. "It's a simple way to bring technology into the OR sooner, providing patients with state-of-the-art care," said co-CEO Marc Viscogliosi. VB Spine describes itself as the largest privately held spine company and among the largest family-owned medical technology companies globally. The company is owned and led by the Viscogliosi Brothers.